Study launched to test hydroxychloroquine as treatment for COVID-19
April 8, 2020
https://news.vumc.org/2020/04/08/nhlbi-launches-study-of-drug-to-treat-covid-19/
Faced with a global pandemic of a virus previously unknown to humans, Vanderbilt University Medical Center (VUMC) is leading a clinical trial to understand if hydroxychloroquine, a well-known drug used for malaria and rheumatologic conditions, is safe and effective in treating hospitalized adults with COVID-19.
Study aims to shield health workers from COVID-19 infection
April 2, 2020
https://news.vumc.org/2020/04/02/study-aims-to-shield-health-workers-from-covid-19-infection/
Vanderbilt University Medical Center is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.